In order to investigate if these new subpopulations of NSCLC MDSCs are functional as well as their possible mechanisms of action, we assessed the expression of ROS and iNOS in all of our subpopulations by flow cytometry (Figure 3(a)). Here, NOS2 is linked to non-small cell lung carcinoma.